Skin manifestations of obesity: A comparative study

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 10, 2012, Pages 1220-1223

  Boza, J C ^a   Trindade, E N ^a   Peruzzo, J ^a   Sachett, L ^a   Rech, L ^a   Cestari, T F ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BACTERIAL INFECTION; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DARIER DISEASE; FEMALE; FIBROMA; HUMAN; INTERTRIGO; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; OBESITY; PALMOPLANTAR KERATODERMA; PRIORITY JOURNAL; PSEUDOACANTHOSIS NIGRICANS; QUALITY OF LIFE; SKIN DISEASE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; SKIN DISEASES;

EID: 84866250488     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04265.x     Document Type: Article

References (26)

1. Yosipovitch G, DeVore A, Dawn A,. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56: 901-916.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
3. Boza JC, Rech L, Sachett L, Menegon DB, Cestari TF,. Skin manifestations of obesity. Rev HCPA 2010; 30: 55-62.
4. Lenz M, Richter T, Mühlhauser I,. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009; 106: 641-648.
5. Scheinfeld NS,. Obesity and dermatology. Clin Dermatol 2004; 22: 303-309.
6. Tyler I, Wiseman MC, Crawford RI, Birmingham CL,. Cutaneous manifestations of eating disorders. J Cutan Med Surg 2002; 6: 345-353.
7. García-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, Villa AR, Dalman JJ, Ortiz-Pedroza G,. Dermatoses in 156 obese adults. Obes Res 1999; 7: 299-302.
8. Guida B, Nino M, Perrino NR, et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol 2010; 24: 191-195.
9. Al-Mutairi N,. Associated cutaneous diseases in obese adult patients: a prospective study from a skin referral care center. Med Princ Pract 2011; 20: 248-252.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
11. Strumia R,. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6: 165-173.
12. Tamega Ade A, Aranha AM, Guiotoku MM, Miot LD, Miot HA,. Association between skin tags and insulin resistance. An Bras Dermatol 2010; 85: 25-31.
13. Jowkar F, Fallahi A, Namazi MR,. Is there any relation between serum insulin and insulin-like growth factor-I in non-diabetic patients with skin tag? J Eur Acad Dermatol Venereol 2010; 24: 73-74.
14. Araújo L, Viveiros A, Lopes R, Viana A, Fukui R, Ursich M,. Acanthosis nigricans em mulheres obesas de uma população miscigenada: um marcador de distúrbios metabõlicos. An Bras Dermatol 2002; 77: 537-543.
15. Hermanns-Le T, Scheen A, Pierard GE,. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5: 199-203.
16. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD,. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992; 128: 941-944.
17. Janniger CK, Schwartz RA, Szepietowski JC, Reich A,. Intertrigo and common secondary skin infections. Am Fam Physician 2005; 72: 833-838.
18. Yosipovitch G, Mevorah B, Mashiach J, Chan YH, David M,. High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris. Dermatology 2000; 201: 34-36.
19. Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E,. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998; 21: 506-509.
20. Davidovici BB, Sattar N, Jörg PC, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
21. Kim N, Thrash B, Menter A,. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010; 29: 10-15.
22. Hercogová J, Ricceri F, Tripo L, Lotti T, Prignano F,. Psoriasis and body mass index. Dermatol Ther 2010; 23: 152-154.
23. Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingård E, Ståhle M,. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-497.
24. Menter A, Griffiths CE, Tebbey PW, Horn EJ, Sterry W, International Psoriasis Council. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol 2010; 24: 1371-1377.
25. Prey S, Paul C, Bronsard V, et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24: 23-30.
26. Jabbour SA,. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol 2003; 4: 315-331.